Inhibition of sympathetic activity following chronic administration of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline (MJ 10459-2).
D000588:Amines / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002339:Carotid Arteries / Q000502:physiology; D002415:Cats; D002714:Chlorisondamine / Q000494:pharmacology; D002722:Chlorobenzenes / Q000494:pharmacology; D003655:Decerebrate State; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D005552:Forelimb / Q000098:blood supply; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D012039:Regional Blood Flow / Q000187:drug effects; D013233:Stellate Ganglion / Q000187:drug effects; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014439:Tyramine / Q000494:pharmacology; D014628:Vagotomy; D014630:Vagus Nerve / Q000187:drug effects / Q000502:physiology; D014655:Vascular Resistance / Q000187:drug effects
D000588:Amines; D000959:Antihypertensive Agents; D002722:Chlorobenzenes; D007093:Imidazoles; D002714:Chlorisondamine; D005703:Gallamine Triethiodide; D009638:Norepinephrine; D014439:Tyramine